These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

80 related items for PubMed ID: 22064158

  • 1. Peroxisome proliferator-activated receptor α (PPARα) activation advances locomotor activity and feeding daily rhythms in mice.
    Gutman R, Barnea M, Haviv L, Chapnik N, Froy O.
    Int J Obes (Lond); 2012 Aug; 36(8):1131-4. PubMed ID: 22064158
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Circadian expression of FGF21 is induced by PPARalpha activation in the mouse liver.
    Oishi K, Uchida D, Ishida N.
    FEBS Lett; 2008 Oct 29; 582(25-26):3639-42. PubMed ID: 18840432
    [Abstract] [Full Text] [Related]

  • 4. Rosiglitazone aggravates nonalcoholic Fatty pancreatic disease in C57BL/6 mice fed high-fat and high-sucrose diet.
    Fernandes-Santos C, Evangelista Carneiro R, de Souza Mendonca L, Barbosa Aguila M, Mandarim-de-Lacerda CA.
    Pancreas; 2009 Apr 29; 38(3):e80-6. PubMed ID: 19214135
    [Abstract] [Full Text] [Related]

  • 5. Role of peroxisome proliferator-activated receptor-alpha (PPARalpha) in bezafibrate-induced hepatocarcinogenesis and cholestasis.
    Hays T, Rusyn I, Burns AM, Kennett MJ, Ward JM, Gonzalez FJ, Peters JM.
    Carcinogenesis; 2005 Jan 29; 26(1):219-27. PubMed ID: 15447978
    [Abstract] [Full Text] [Related]

  • 6. Bezafibrate induces plasminogen activator inhibitor-1 gene expression in a CLOCK-dependent circadian manner.
    Oishi K, Koyanagi S, Matsunaga N, Kadota K, Ikeda E, Hayashida S, Kuramoto Y, Shimeno H, Soeda S, Ohdo S.
    Mol Pharmacol; 2010 Jul 29; 78(1):135-41. PubMed ID: 20400680
    [Abstract] [Full Text] [Related]

  • 7. Bezafibrate, a peroxisome proliferator-activated receptors agonist, decreases body temperature and enhances electroencephalogram delta-oscillation during sleep in mice.
    Chikahisa S, Tominaga K, Kawai T, Kitaoka K, Oishi K, Ishida N, Rokutan K, Séi H.
    Endocrinology; 2008 Oct 29; 149(10):5262-71. PubMed ID: 18787029
    [Abstract] [Full Text] [Related]

  • 8. Activation of peroxisome proliferator-activated receptor-α (PPARα) suppresses postprandial lipidemia through fatty acid oxidation in enterocytes.
    Kimura R, Takahashi N, Murota K, Yamada Y, Niiya S, Kanzaki N, Murakami Y, Moriyama T, Goto T, Kawada T.
    Biochem Biophys Res Commun; 2011 Jun 24; 410(1):1-6. PubMed ID: 21640707
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Rosiglitazone and bezafibrate modulate gene expression in a rat model of non-alcoholic fatty liver disease--a historical prospective.
    Schmilovitz-Weiss H, Hochhauser E, Cohen M, Chepurko Y, Yitzhaki S, Grossman E, Leibowitz A, Ackerman Z, Ben-Ari Z.
    Lipids Health Dis; 2013 Mar 25; 12():41. PubMed ID: 23531105
    [Abstract] [Full Text] [Related]

  • 14. The direct antioxidative and anti-inflammatory effects of peroxisome proliferator-activated receptors ligands are associated with the inhibition of angiotensin converting enzyme expression in streptozotocin-induced diabetic rat aorta.
    Toba H, Miki S, Shimizu T, Yoshimura A, Inoue R, Sawai N, Tsukamoto R, Murakami M, Morita Y, Nakayama Y, Kobara M, Nakata T.
    Eur J Pharmacol; 2006 Nov 07; 549(1-3):124-32. PubMed ID: 16979161
    [Abstract] [Full Text] [Related]

  • 15. Cholesterol-lowering effect of bezafibrate is independent of peroxisome proliferator-activated receptor activation in mice.
    Nakajima T, Tanaka N, Sugiyama E, Kamijo Y, Hara A, Hu R, Li G, Li Y, Nakamura K, Gonzalez FJ, Aoyama T.
    Biochem Pharmacol; 2008 Jul 01; 76(1):108-19. PubMed ID: 18486101
    [Abstract] [Full Text] [Related]

  • 16. Concomitant suppression of hyperlipidemia and intestinal polyp formation in Apc-deficient mice by peroxisome proliferator-activated receptor ligands.
    Niho N, Takahashi M, Kitamura T, Shoji Y, Itoh M, Noda T, Sugimura T, Wakabayashi K.
    Cancer Res; 2003 Sep 15; 63(18):6090-5. PubMed ID: 14522940
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Circadian rhythms of gene expression of lipid metabolism in Gilthead Sea bream liver: synchronisation to light and feeding time.
    Paredes JF, Vera LM, Martinez-Lopez FJ, Navarro I, Sánchez Vázquez FJ.
    Chronobiol Int; 2014 Jun 15; 31(5):613-26. PubMed ID: 24517141
    [Abstract] [Full Text] [Related]

  • 19. Weight-loss-associated induction of peroxisome proliferator-activated receptor-alpha and peroxisome proliferator-activated receptor-gamma correlate with reduced atherosclerosis and improved cardiovascular function in obese insulin-resistant mice.
    Verreth W, De Keyzer D, Pelat M, Verhamme P, Ganame J, Bielicki JK, Mertens A, Quarck R, Benhabilès N, Marguerie G, Mackness B, Mackness M, Ninio E, Herregods MC, Balligand JL, Holvoet P.
    Circulation; 2004 Nov 16; 110(20):3259-69. PubMed ID: 15533870
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.